Peter B Gilbert Selected Research

AIDSVAX B-E

1/2021	Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
4/2013	Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
8/2009	Blood and seminal plasma HIV-1 RNA levels among HIV-1-infected injecting drug users participating in the AIDSVAX B/E efficacy trial in Bangkok, Thailand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter B Gilbert Research Topics

Disease

73	Infections 12/2021 - 07/2003
24	HIV Infections (HIV Infection) 01/2022 - 09/2003
18	COVID-19 11/2022 - 11/2020
14	Dengue (Dengue Fever) 05/2022 - 01/2018
10	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 12/2002
5	Communicable Diseases (Infectious Diseases) 03/2021 - 05/2010
4	Disease Progression 10/2022 - 09/2005
4	Breakthrough Infections 01/2021 - 09/2004
4	Human Influenza (Influenza) 05/2019 - 01/2007
3	Virus Diseases (Viral Diseases) 11/2020 - 11/2013
3	Vaccinia 01/2017 - 11/2014
2	Vesicular Stomatitis 01/2020 - 11/2017
2	Herpes Zoster 01/2018 - 11/2014
2	Viremia 10/2013 - 07/2003
2	Neoplasms (Cancer) 01/2010 - 03/2005
1	Hepatitis C 01/2021
1	Severe Acute Respiratory Syndrome 11/2020
1	Coronavirus Infections 11/2020
1	Malaria 01/2019
1	Persistent Infection 09/2011
1	Colorectal Neoplasms (Colorectal Cancer) 03/2005

Drug/Important Bio-Agent (IBA)

100	VaccinesIBA 11/2022 - 07/2003
24	AIDS VaccinesIBA 01/2021 - 07/2003
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2003
13	AntibodiesIBA 01/2022 - 06/2006
10	Dengue VaccinesIBA 05/2022 - 01/2018
9	Neutralizing AntibodiesIBA 05/2022 - 05/2015
9	Immunoglobulin G (IgG)IBA 04/2022 - 04/2012
9	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2012
9	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 05/2006
6	Broadly Neutralizing AntibodiesIBA 01/2022 - 09/2011
6	Glycoproteins (Glycoprotein)IBA 09/2019 - 03/2005
5	CYD-TDV vaccineIBA 01/2022 - 01/2018
5	Immunoglobulin A (IgA)IBA 11/2019 - 04/2012
4	COVID-19 VaccinesIBA 04/2022 - 11/2020
4	2019-nCoV Vaccine mRNA-1273IBA 12/2021 - 08/2021
4	Peptides (Polypeptides)IBA 01/2017 - 11/2006
3	EpitopesIBA 10/2022 - 09/2009
3	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 09/2021
3	Adenosine Monophosphate (AMP)IBA 02/2021 - 01/2017
3	AIDSVAXIBA 01/2021 - 04/2013
3	AIDSVAX B-EIBA 01/2021 - 08/2009
3	A-Form DNA (A-DNA)IBA 11/2019 - 11/2013
3	AntigensIBA 01/2014 - 03/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2022 - 01/2022
2	ImmunosorbentsIBA 07/2018 - 01/2018
2	EnzymesIBA 07/2018 - 01/2018
2	Herpes Zoster VaccineIBA 01/2018 - 11/2014
2	Fc Receptors (Fc Receptor)IBA 09/2014 - 05/2007
2	RNA (Ribonucleic Acid)IBA 11/2013 - 09/2005
2	Viral RNAIBA 02/2012 - 08/2009
2	Amino Acids FDA Link 09/2011 - 04/2008
2	Zidovudine (Retrovir)FDA LinkGeneric 08/2006 - 06/2006
1	Ad26COVS1IBA 04/2022
1	BNT162 VaccineIBA 01/2021
1	Ebola VaccinesIBA 01/2020
1	env Gene ProductsIBA 11/2019
1	IgG Receptors (Fc gamma RI)IBA 11/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2019
1	Neuraminidase (Sialidase)IBA 05/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Interleukin-15 (Interleukin 15)IBA 01/2019
1	CytokinesIBA 01/2019
1	ChemokinesIBA 01/2019
1	MF59 oil emulsionIBA 01/2018
1	Combined VaccinesIBA 01/2018
1	DNA VaccinesIBA 11/2017
1	Interleukin-12 (IL 12)IBA 11/2017
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	GP 140IBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2014
1	InterferonsIBA 01/2014
1	HLA-B Antigens (HLA-B)IBA 10/2013
1	Pharmaceutical PreparationsIBA 02/2013
1	ORALIT (ORS)IBA 01/2013
1	SAIDS VaccinesIBA 02/2012
1	Fc gamma receptor IIAIBA 05/2007
1	Nevirapine (Viramune)FDA Link 06/2006
1	Chemokine ReceptorsIBA 04/2006
1	Biological ProductsIBA 12/2005
1	ParaffinIBA 03/2005
1	recombinant soluble CD4IBA 03/2005
1	Formaldehyde (Formol)FDA Link 03/2005

Therapy/Procedure

5	Therapeutics 01/2021 - 07/2003
2	Art Therapy 01/2022 - 09/2005
1	Intramuscular Injections 01/2018
1	Intravenous Infusions 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 06/2006
1	Drug Therapy (Chemotherapy) 12/2002